AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Lamivudine; Zidovudine in Nigeria
5 products registered with NAFDAC — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Lamivudine/Zidovudine Dispersible Tablets USP 30 mg/60 mg Tablet | B4-8258 | Healthline Limited | active | 27 Feb 2029 |
| Avocomb Tablets 150/300 mg (no NRN) Tablet | UNKNOWN-bdce9ebe | Ranbaxy Nigeria Limited | active | 27 Mar 2028 |
| Avocomb Tablets 150/300 mg (no NRN) Tablet | UNKNOWN-3ef1330a | Ranbaxy Nigeria Limited | active | 27 Mar 2028 |
| Lamivudine/Zidovudine** Tablet | A4-2583 | May & Baker Nigeria PLC | active | 6 May 2026 |
| Lamivudine 150 mg, Zidovudine 300 mg Tablets USP Tablet | A4-1362 | Healthline Limited | active | 20 Dec 2025 |
Lamivudine; Zidovudine — NAFDAC Registration Details
NAFDAC (Nigeria) has 5 registered products containing Lamivudine; Zidovudine, of which 5 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Lamivudine; Zidovudine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.